Background. The value of circulating CA 15-3 levels was assessed in 129 patients with recurrent breast carcinoma. Methods. Patients were divided into four subgroups, according to the following: Group A, locoregional recurrence alone; Group B, locoregional and subsequent systemic recurrence; Group C
โฆ LIBER โฆ
The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancer
โ Scribed by Linda C. Pronk; Gerrit Stoter; Wim L. J. van Putten; Ronald de Wit
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 421 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
CA 15-3 in patients with locoregional an
โ
J. G. Geraghty; E. C. Coveney; F. Sherry; N. J. O'Higgins; M. J. Dufy
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 341 KB
๐ 2 views
Clinical significance of a serum CA15-3
โ
Hyo Song Kim; Yeon Hee Park; Min Jae Park; Myung Hee Chang; Hyun Jung Jun; Kyoun
๐
Article
๐
2009
๐
Springer US
๐
English
โ 279 KB
Clinical significance of a serum CA 15-3
โ
Shih-Chung Wu; Fong-Fu Chou; Kun-Ming Rau
๐
Article
๐
2010
๐
Springer US
๐
English
โ 129 KB
Prognostic role of CA15.3 in 7942 patien
โ
M. T. Sandri; M. Salvatici; E. Botteri; R. Passerini; L. Zorzino; N. Rotmensz; A
๐
Article
๐
2011
๐
Springer US
๐
English
โ 275 KB
Characterization of metastatic breast ca
โ
Michal Mego; Ugo De Giorgi; Shahenaah Dawood; Xuemei Wang; Vicente Valero; Eleni
๐
Article
๐
2010
๐
John Wiley and Sons
๐
French
โ 159 KB
๐ 1 views
## Abstract Circulating tumor cells (CTC) are an independent prognostic factor in metastatic breast cancer patients (MBC). However, CTC are undetectable in one third of patients. The aim of this study was to assess the prognostic factors in MBC patients without detectable CTC. This retrospective st
A correlation between the incorporation
โ
Sydney Kofman; Howard H. Sky-Peck; Charles P. Perlia; Steven G. Economou; Richar
๐
Article
๐
1960
๐
John Wiley and Sons
๐
English
โ 544 KB